TheEdgeResearch
Home / Stocks / ANTCF

Aion Therapeutic Inc. (ANTCF)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.00 ▲ +0.00%
Market Cap
$2.1M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
4.71
52-Wk Range
0.0017-0.015
CEO
John Graham Simmonds Jr.
Country
CA
Currency
USD

Aion Therapeutic Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Vancouver, BC, CA. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $2.1M. On trailing twelve-month figures it carries a trailing P/E of -0.21, a net margin of -1710.9%. Its beta of 4.71 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-0.21
Price / Sales
6.76
Price / Book
-0.34
EV / EBITDA
-0.74
Gross margin
44.4%
Operating margin
-324.1%
Net margin
-1710.9%
Return on equity
—
Debt / equity
-0.54
Current ratio
0.12
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
5
IPO date
2021-04-21
Headquarters
Vancouver, BC, CA
About Aion Therapeutic Inc.

Headquartered in Toronto, Canada, Aion Therapeutic Inc. provides medical cannabis products across the nation. The company, which was established in 2011, formerly operated as Osoyoos Cannabis Inc. until it officially adopted its current name in August 2020.

Comparable companies

Aion Therapeutic Inc. is most often compared with the following Healthcare names:

BHNGFCPMDEVIOFWDGHEMPJWCAFKAYSKHRNFPLSHSHMN
More research on ANTCF
ANTCF technical analysis ANTCF TheEdge Score Compare against peers
Open full interactive analysis & DCF →